Clinical Trial

Efficacy of Vonoprazan-based Rescue Therapy for H. Pylori Eradication

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
1. This study aims to compare the efficacy of empirical vonoprazan-based therapy versus susceptibility-guided vonoprazan-based therapy for third-line eradication of H. pylori. 2. We also plan to explore the impact of eradication therapy on gut microbiota, fecal antibiotic resistance, and metabolic parameters before and after treatment.
Trial Details
NCT Number NCT07130253
Lead Sponsor National Taiwan University Hospital
Conditions HELICOBACTER PYLORI INFECTIONS
Enrollment 220 participants
Start Date 2025-08-18
Primary Completion 2028-06-30 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-19